Skip to main content

Table 1 Patient characteristics

From: Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery

  Amiodarone (n = 11) Control (n = 15) p-values
Age, years (mean ± SD) 67.2 ± 7.5 71.7 ± 6.5 0.100
Men/Women, n 4/7 6/9 0.851
Cardiovascular comorbidity, n   
 Valvular heart disease 8 13  
 Ischemic heart disease 1 0  
 Thoracic aortic aneurysm 1 0  
 Aortic dissection 0 1  
 Aortic dissection + Ischemic heart disease 1 0  
 Valvular heart disease + Ischemic heart disease 0 1  
Warfarin indication (preoperative), n   
 Atrial fibrillation 4 11  
 Post prosthetic valve replacement 4 4  
 Low LVEF 3 0  
Dosage of warfarin (baseline), mg/day (mean ± SD) 2.64 ± 0.89 3.07 ± 1.22 0.370
PT-INR value (baseline) (mean ± SD) 2.13 ± 0.58 2.27 ± 0.58 0.551
  1. LVEF left ventricular ejection fraction